EMC1.F
Ems-Chemie Holding AG N

Basic Materials · Specialty Chemicals · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

6.46B USD

Market Cap

22.95B USD

Margin of Safety

-255.1%

Intrinsic / Market Ratio

0.28×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

7.96B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

5.83B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

5.60B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

6.46B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

6.46B USD

from the sum above

Market Cap

22.95B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.28×

the ratio the screener ranks by; Margin of Safety -255.1% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 7.96B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)5.94B USD
+②Net Cash Today960.79M USD
+③Growth Value1.06B USD
=Value7.96B USD

EPV of the Operations (NOPAT over WACC)

5.94B USD

Net cash today

+960.79M USD

Growth Value

+1.06B USD

Value

7.96B USD

①EPV (earnings power value)

5.94B USD

②Net Cash Today

960.79M USD

③Growth Value

1.06B USD

Market value

Market Cap22.95B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-188.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 5.83B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE4.68B USD
+②Equity at Year 15, Today1.16B USD
=Value5.83B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

4.68B USD

②Equity at Year 15, Today

1.16B USD

Market value

Market Cap22.95B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-293.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 5.60B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF4.07B USD
+②Invested Capital at Year 15, Today568.77M USD
+③Net Cash Today960.79M USD
=Value5.60B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

4.07B USD

②Invested Capital at Year 15, Today

568.77M USD

③Net Cash Today

960.79M USD

Market value

Market Cap22.95B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-309.9%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.34%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.81×Market Risk Premium 6.00%= 9.34%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 117.63M USDPretax Income 712.93M USD= 16.50%

The tax the interest saves.

Interest Expense =EBIT 714.06M USD−Pretax Income 712.93M USD= 1.14M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 1.14M USDTotal Debt 8.68M USD×(1 − Tax Rate for WACC 16.50%)= 10.96%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 8.68M USDMarket Cap + Total Debt 22.95B USD + 8.68M USD= 0.04%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.96%×Cost of Equity 9.34%+Debt Weight 0.04%×Cost of Debt 10.96%= 9.34%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 3.20B USD − Total Liabilities 599.47M USD = Book Value Today 2.60B USD

Total Debt 8.68M USD − Cash and Short-Term Investments 969.47M USD = Net Debt Today -960.79M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.0%at most 5%passes23,389,028 / 23,389,028
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.7%at least -10.0%passes(675.60M USD − 589.83M USD) ÷ 3.20B USD
Price to bookMarket Cap ÷ Book Value Today8.81×at most 3×does not pass22.95B USD ÷ 2.60B USD
Operating marginOperating Income ÷ Revenue29.1%above 10.0%passes717.99M USD ÷ 2.47B USD
Revenue growthRevenue ÷ Revenue a Year Before − 17.4%above 10.0%does not pass2.47B USD / 2.29B USD
Net cash(Cash − Total Debt) ÷ Market Cap4.2%above -30%passes(969.47M USD − 8.68M USD) ÷ 22.95B USD
Operating efficiencyOperating Income ÷ Gross Profit58.6%above 25.0%passes717.99M USD ÷ 1.23B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

875.87 EUR

Enterprise value

19.39B EUR

the provider's own figure

EV / EBITDA

30.80×

Price / book

9.31×

the provider's book

Price / earnings

40.81×

Return on equity

22.7%

the provider's figure, not this page's

Profit margin

24.4%

Revenue growth

-0.9%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

2.65B2.60B2.29B2.47B

Gross profit

1.10B1.05B1.08B1.23B

Operating income

662.92M585.28M598.31M717.99M

EBITDA

operating income before depreciation and amortisation

713.42M643.73M667.98M783.96M

Pretax income

657.91M583.88M608.46M712.93M

Net income

577.16M543.11M510.66M589.83M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

577.25M543.73M511.39M590.73M

R&D

————
Balance sheet, year end

Total assets

2.51B2.57B2.47B2.82B

Total liabilities

511.55M473.06M401.74M465.31M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.97B2.07B2.03B2.35B

Total debt

14.67M38.38M9.73M41.09M

Cash and equivalents

269.61M313.80M574.47M762.53M

Net PP&E

fixed assets after depreciation

673.27M724.56M657.37M712.62M

Working capital

current assets less current liabilities

1.30B1.28B1.35B1.60B
Cash flow

Operating cash flow

396.88M684.22M532.36M675.60M

Capital expenditure

paid out, so below zero

-101.92M-58.62M-36.41M-35.89M

Depreciation and amortisation

54.69M58.90M58.27M69.89M

Free cash flow

operating cash flow plus capital expenditure

294.95M625.60M495.95M639.71M